+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling



SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling



Journal of Translational Medicine 3: 44



The goal of this study was to evaluate changes in gene expression in SW-620 cells in response to SN-38 in order to further elucidate the mechanisms by which SN-38 causes apoptosis and cell cycle arrest. We used a quantitative gene expression microarray assay to identify the genes regulated by SN-38 treatment in colon cancer cells and confirmed our results with RT-PCR. By gene expression profiling, we first screened a proprietary list of about 22,000 genes. Treatment with SN-38 cells resulted in two-fold or greater alteration in the level of expression of 192 genes compared to control treatment. Most of the affected genes were not known to be responsive to SN-38 prior to this study. SN-38 treatment of these cells was found to affect the expression of various genes involved in DNA replication, transcription, signal transduction, growth factors, cell cycle regulation, and apoptosis, as well as other genes with unknown function. Changes in expression of 14 genes were confirmed by quantitative real-time polymerase chain reaction (RT-PCR). This study leads to an increased understanding of the biochemical pathways involved in SN-38-induced apoptosis and possibly to the identification of new therapeutic targets.

(PDF emailed within 0-6 h: $19.90)

Accession: 050248942

Download citation: RISBibTeXText

PMID: 16375766

DOI: 10.1186/1479-5876-3-44


Related references

Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide Isomerases. Acs Omega 3(12): 17227-17235, 2019

Kinetoplast-associated DNA topoisomerase in Crithidia fasciculata: crosslinking of mitochondrial topoisomerase II to both minicircles and maxicircles in cells treated with the topoisomerase inhibitor VP16. Nucleic Acids Research. July 11; 2013: 3353-3356, 1992

Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Experimental Eye Research 88(6): 1020-1032, 2009

Repositioning of ETO gene in cells treated with VP-16, an inhibitor of DNA-topoisomerase II. Journal of Cellular Biochemistry 104(2): 692-699, 2008

Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Research 67(7): 3239-3253, 2007

Co-amplification of DNA topoisomerase IIalpha and retinoic acid alpha receptor gene in treated cancer cell lines by a topoisomerase I inhibitor, CPT-11. Proceedings of the American Association for Cancer Research Annual Meeting 42: 256, 2001

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response. Breast 16(1): 86-93, 2006

Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Letters 293(1): 124-131, 2010

Gene expression profiling and functional analysis reveals that p53 pathway-related gene expression is highly activated in cancer cells treated by cold atmospheric plasma-activated medium. Peerj 5: E3751, 2017

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. Biochimica et Biophysica Acta 1693(3): 167-176, 2004

Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor. Transplant Immunology 20(3): 0-142, 2009

Gene expression profiling in apoptotic k562 cells treated by homoharringtonine. Acta Biochimica et Biophysica Sinica 39(12): 982-991, 2007

Gene expression profiling of Ca2+-ATPase inhibitor DTBHQ and antigen-stimulated RBL-2H3 mast cells. Inflammation Research 51(12): 611-618, 2002

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer. Breast Cancer Research and Treatment 122(2): 419-428, 2010

Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. Neurotoxicology 28(5): 979-987, 2007